Study: COVID Recovery Gave Israelis Longer-Lasting Delta Defense Than Vaccines

This article was first published by The Times of Israel and is re-posted with permission.

Natural immunity from contracting coronavirus provided Israelis with longer-lasting protection against the Delta variant than two shots of the Pfizer vaccine given early this year, new Israeli research suggests.

The study by Maccabi Healthcare Service looked at individuals who had either gotten two shots of the vaccine by the end of February or tested positive for COVID-19 by that time.

SEE ALSO: Antiviral Drug Reduces COVID-19 Inflammation In 48 Hours, Israeli Study Finds

It compared 46,035 Maccabi members who caught the coronavirus at some point during the pandemic and the same number of double-vaccinated people.

To read the full article, click here.